Skip to main content
. 2023 Mar 27;99(5):209–218. doi: 10.5414/CN111111

Figure 1. Serum levels of FGF-23 (A) and sclerostin (B) in controls and CKD stages 2 – 5D patients. Open circles represent the outliers. Median values with different letters are significantly different, p < 0.05.

Figure 1.